title: Evaluation of a flow cytometric model for monitoring HIV antigen expression in vitro.
abstract: Using flow cytometry, monoclonal antibodies to the HIV proteins p24, gp41 and p17 were evaluated for their ability to detect HIV antigens associated with HIV-infected T cells. Mixtures containing varying ratios of HIV-infected and uninfected cells were subjected to analysis with these monoclonal antibodies. In most cases, the monoclonal antibodies identified the correct ratio of HIV-infected cells to uninfected cells in the mixtures tested. An HIV anti-p24 monoclonal antibody was selected for further studies. Flow cytometric analysis was performed on various populations of cells including uninfected, acutely infected and chronically infected cells. Based on cell population fluorescence intensity three distinct regions were identified. In the first region were cells having low level fluorescence that were considered negative for HIV antigens, a profile detected in uninfected cells, and in the majority of cells in the first days following acute HIV infection. In the second region were those cells exhibiting strong fluorescence such as chronically infected cells or acutely infected cells several days after infection. A third region was identified containing cells that were intermediate in fluorescence intensity. Cells exhibiting intermediate intensity fluorescence appeared to have low concentrations of HIV p24 antigen associated with them either through viral adsorption and uptake or through low level virus expression. These intermediate region cells appeared in the early stages following acute infection, and also when chronically infected cells and uninfected cells were permeabilized together, suggesting a 'leaching' of HIV proteins from highly infected cells to uninfected cells. This leaching type of phenomenon could present problems in determining gating parameters for positive cells since uninfected cells that have associated HIV antigens exhibit higher fluorescence intensity than uninfected cells.
authors.affiliation: Abbott Laboratories, Department of Experimental Biology Research, North Chicago, IL 60064.
authors.forename: C A
authors.initials: CA
authors.lastname: Heynen
authors.forename: T J
authors.initials: TJ
authors.lastname: Holzer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D005434:Flow Cytometry / Q000379:methods*; D015483:HIV Antibodies / Q000737:chemistry; D015488:HIV Antigens / Q000032:analysis* / Q000276:immunology; D016655:HIV Core Protein p24 / Q000032:analysis* / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000032:analysis / Q000276:immunology; D015658:HIV Infections / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D010455:Peptides / Q000032:analysis / Q000276:immunology; D013601:T-Lymphocytes / Q000737:chemistry / Q000276:immunology / Q000382:microbiology; D054301:gag Gene Products, Human Immunodeficiency Virus
chemical_list: D000911:Antibodies, Monoclonal; C052407:HGP-30 peptide, Human immunodeficiency virus-1; D015483:HIV Antibodies; D015488:HIV Antigens; D016655:HIV Core Protein p24; D015700:HIV Envelope Protein gp41; D010455:Peptides; D054301:gag Gene Products, Human Immunodeficiency Virus